---
schema_version: "secwatch.filing_event.v1"
accession: "0001818093-22-000017"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2022-01-20T23:59:59+00:00"
generated_at: "2026-06-27T16:54:18.801060+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Beauty Health appoints Andrew Stanleick as President and CEO, effective Feb 7, 2022

## Summary
- Andrew Stanleick appointed President, CEO and board member effective Feb 7, 2022; Brent Saunders remains Executive Chairman.
- Base salary $800,000; target annual bonus 100% of base; $800,000 signing cash bonus subject to clawback within 12 months.
- Equity: 250,000 performance-based RSUs (stock price goals over 4 years); FY2022 annual grants of $4.5M time-based RSUs and $1.5M PSUs.
- Stanleick brings 25+ years beauty/retail experience, most recently EVP Americas at Coty and CEO of Kylie Jenner Beauty.

## SEC filing metadata
- accession: 0001818093-22-000017
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2022-01-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000017/0001818093-22-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000017/skin-20220120.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818093-22-000017
- JSON: https://secwatch.observer/filing/0001818093-22-000017.json
- Plain text: https://secwatch.observer/filing/0001818093-22-000017.txt

## Key facts
- Executive change
  Brenton L. Saunders changed role as Interim Chief Executive Officer at SkinHealth Systems Inc..
  - Action: ceased to serve
  - Role: Interim Chief Executive Officer
  source text: Upon Mr. Stanleick commencing employment as the Company’s Chief Executive Officer, Brenton L. Saunders, the current interim Chief Executive Officer of the Company and the Executive Chairman of the Board, will cease to serve as interim Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000017/0001818093-22-000017-index.htm
- Executive change
  Andrew Stanleick was appointed as President and Chief Executive Officer at SkinHealth Systems Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On January 20, 2022, The Beauty Health Company (the “Company”) announced the appointment of Andrew Stanleick to serve as its President and Chief Executive Officer and as a member of the Company’s Board of Directors (the “Board”), effective as of February 7, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000017/0001818093-22-000017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.